incyte.jp | バイオ医薬品企業 | アンメットメディカルニーズへのソリューション

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
# Begin robots.txt file #/-----------------------------------------------\ #\| In single portal/domain situations, uncomment the sitmap line and enter domain name #\-----------------------------------------------/ #Sitemap: http://www.DomainNamehere.com/sitemap.aspx User-agent: * Disallow: //ctl/ # Googlebot permits Disallow: /admin/ Disallow: /App_Browsers/ Disallow: /App_Code/ Disallow: /App_Data/ Disallow: /App_GlobalResources/ Disallow: /bin/ Disallow: /Components/ Disallow: /Config/ Disallow: /contest/ Disallow: /controls/ Disallow: /Documentation/ Disallow: /HttpModules/ Disallow: /Install/ Disallow: /Providers/ Disallow: /Activity-Feed/userId/ # Do not index user profiles

Meta Tags

Title	バイオ医薬品企業 \| アンメットメディカルニーズへのソリューション
Description	あなたはIncyte.comのウェブサイトから移動しようとしています。 --> 同意して閉じる This copy is not licensed. Proceed to activation screen. --> 当社について当社の活動についてニュース医療関係者の皆様お問い合わせ当社について当社についてインサイト・ジャパンについて当社の活動につい
Keywords	N/A

Server Information

WebSite	incyte.jp
Host IP	13.78.123.87
Location	United States

さらに探索する

Site

incyte.jp 評価

US$1,065,503

最終更新: 2022-10-07 02:42:50

incyte.jp の Semrush グローバルランクは 9,933,624 です。incyte.jp は、推定広告収入に基づいて、US$1,065,503 の推定価値を持っています。 incyte.jp には、毎日約 122,943 人のユニークユーザーがアクセスしています。その Web サーバーは United States にあり、IP アドレスは 13.78.123.87です。 SiteAdvisor によると、incyte.jp は安全にアクセスできます。

トラフィック & 見積もりの価値

売買価格	US$1,065,503
毎日の広告収入	US$984
月間広告収入	US$29,507
年間広告収入	US$354,075
デイリーユニークビジター	8,197
注: トラフィックと収益の値はすべて推定値です。

DNS Records

Host	Type	TTL	Data
incyte.jp.	A	14398	IP: 13.78.123.87
incyte.jp.	NS	14400	NS Record: dns1.cscdns.net.
incyte.jp.	NS	14400	NS Record: dns2.cscdns.net.
incyte.jp.	MX	14400	MX Record: 10 custmx.cscdns.net.
incyte.jp.	TXT	14400	TXT Record: incyte-jp.azurewebsites.net

HtmlToTextCheckTime:2022-10-07 02:42:50

--> 同意して閉じる This copy is not licensed. Proceed to activation screen. --> 当社について当社の活動についてニュース医療関係者の皆様お問い合わせ当社について当社についてインサイト・ジャパンについて当社の活動について当社の活動についてインサイトの主な開発対象ニュース医療関係者の皆様お問い合わせお問い合わせ当社の事業所当社医薬品に関して We’re not the only ones looking for Answers Today --> We Don’t need to look far for Motivation --> Our life’s work is measured in Lifetimes --> --> Incyte International Locations 北米本社デンマークイタリアスペイン英国欧州本社フィンランド日本スウェーデンオーストリアフランスオランダスイスカナダドイツノルウェーポルトガル閉じる利用規約個人情報の取り扱いについてクッキーについてサイトマップ Legal Notice Privacy Cookies Opt Out Site Map Copyright 2022 by Incyte Japan --> Copyright 2022 by Incyte Japan あなたはIncyte.comのウェブサイトから移動しようとしています。このまま続けますか？はい , 移動先の画面を表示して下さいいいえ ,

HTTP Headers

HTTP/1.1 301 Moved Permanently
Content-Length: 0
Content-Type: text/html; charset=UTF-8
Location: https://incyte.jp/
Date: Thu, 27 Jan 2022 10:36:55 GMT

HTTP/1.1 301 Moved Permanently
Cache-Control: max-age=345600, private
Content-Length: 139
Content-Type: text/html; charset=utf-8
Location: https://www.incyte.jp/
Set-Cookie: dnn_IsMobile=False; path=/; HttpOnly
X-Redirect-Reason: Wrong Portal Alias Requested
X-XSS-Protection: 1; mode=block
X-Frame-Options: SAMEORIGIN
Content-Security-Policy: script-src 'self' 'unsafe-inline' 'unsafe-eval' https://fonts.googleapis.com https://www.google-analytics.com https://www.google.com https://www.gstatic.com https://code.jquery.com https://maxcdn.bootstrapcdn.com https://www.googletagmanager.com https://connect.facebook.net https://static.ads-twitter.com https://snap.licdn.com https://bat.bing.com https://analytics.twitter.com; style-src https://fonts.googleapis.com https://fast.fonts.net https://maxcdn.bootstrapcdn.com 'self' 'unsafe-inline';font-src https://fonts.gstatic.com https://maxcdn.bootstrapcdn.com 'self';frame-src 'self' https://www.google.com https://www.facebook.com; frame-ancestors 'self'; img-src 'self' https://www.google-analytics.com https://www.google.com https://t.co https://px.ads.linkedin.com https://bat.bing.com https://www.facebook.com https://p.adsymptotic.com https://www.googletagmanager.com; connect-src 'self' https://www.google-analytics.com https://stats.g.doubleclick.net; default-src 'self';
Strict-Transport-Security: max-age=31536000; includeSubDomains; preload
X-Content-Type-Options: nosniff
Referrer-Policy: strict-origin-when-cross-origin
Permissions-Policy: autoplay=(), payment=(), usb=()
Date: Thu, 27 Jan 2022 10:36:56 GMT

HTTP/1.1 200 OK
Cache-Control: no-cache,max-age=345600, private
Pragma: no-cache
Content-Length: 39553
Content-Type: text/html; charset=utf-8
Expires: -1
Set-Cookie: dnn_IsMobile=False; path=/; HttpOnly
Set-Cookie: language=en-US; path=/; HttpOnly
Set-Cookie: .ASPXANONYMOUS=2yMxI5W3LswB9f5LqVJe24PrfRcwG94im-8v4iU4yXTuFvd82F3b6xAy1FVG2sK_QWYDY4z4zw62Y7pUjqK2TEA2GIHVLf-y-dqWPcQRjqRs-n_20; expires=Wed, 06-Apr-2022 21:16:58 GMT; path=/; HttpOnly
Set-Cookie: dnn_IsMobile=False; path=/; HttpOnly
Set-Cookie: language=en-US; path=/; HttpOnly
Set-Cookie: .ASPXANONYMOUS=2yMxI5W3LswB9f5LqVJe24PrfRcwG94im-8v4iU4yXTuFvd82F3b6xAy1FVG2sK_QWYDY4z4zw62Y7pUjqK2TEA2GIHVLf-y-dqWPcQRjqRs-n_20; expires=Wed, 06-Apr-2022 21:16:58 GMT; path=/; HttpOnly
Set-Cookie: __RequestVerificationToken=2-BlyB4mwNd2q_Q-h4OPVd1MGyjwl_-kAFWcEb3ZQN_Xc53Ucc2We8FrN53zR7mUcCcEXQ2; path=/; HttpOnly
X-UA-Compatible: IE=edge
X-XSS-Protection: 1; mode=block
X-Frame-Options: SAMEORIGIN
Content-Security-Policy: script-src 'self' 'unsafe-inline' 'unsafe-eval' https://fonts.googleapis.com https://www.google-analytics.com https://www.google.com https://www.gstatic.com https://code.jquery.com https://maxcdn.bootstrapcdn.com https://www.googletagmanager.com https://connect.facebook.net https://static.ads-twitter.com https://snap.licdn.com https://bat.bing.com https://analytics.twitter.com; style-src https://fonts.googleapis.com https://fast.fonts.net https://maxcdn.bootstrapcdn.com 'self' 'unsafe-inline';font-src https://fonts.gstatic.com https://maxcdn.bootstrapcdn.com 'self';frame-src 'self' https://www.google.com https://www.facebook.com; frame-ancestors 'self'; img-src 'self' https://www.google-analytics.com https://www.google.com https://t.co https://px.ads.linkedin.com https://bat.bing.com https://www.facebook.com https://p.adsymptotic.com https://www.googletagmanager.com; connect-src 'self' https://www.google-analytics.com https://stats.g.doubleclick.net; default-src 'self';
Strict-Transport-Security: max-age=31536000; includeSubDomains; preload
X-Content-Type-Options: nosniff
Referrer-Policy: strict-origin-when-cross-origin
Permissions-Policy: autoplay=(), payment=(), usb=()
Date: Thu, 27 Jan 2022 10:36:57 GMT

incyte.jp Whois Information

[ JPRS database provides information on network administration. Its use is    ]
[ restricted to network administration purposes. For further information,     ]
[ use 'whois -h whois.jprs.jp help'. To suppress Japanese output, add'/e'     ]
[ at the end of command, e.g. 'whois -h whois.jprs.jp xxx/e'.                 ]
Domain Information: [ドメイン情報]
[Domain Name]                   INCYTE.JP
[登録者名]                      Incyte Corporation
[Registrant]                    Incyte Corporation
[Name Server]                   dns1.cscdns.net
[Name Server]                   dns2.cscdns.net
[Signing Key]
[登録年月日]                    2018/05/01
[有効期限]                      2022/05/31
[状態]                          Active
[最終更新]                      2021/06/01 01:05:09 (JST)
Contact Information: [公開連絡窓口]
[名前]                          Incyte Corporation
[Name]                          Incyte Corporation
[Email]                         IT_DNS_Admins@incyte.com
[Web Page]
[郵便番号]                      19803
[住所]                          1801 Augustine Cutoff
Wilmington
DE US
[Postal Address]
[電話番号]                      +1.3024985808
[FAX番号]                       +1.3024985808

incyte.jp 評価と分析